25939452|t|Adenosine A(2A) receptors are necessary and sufficient to trigger memory impairment in adult mice.
25939452|a|BACKGROUND AND PURPOSE: Caffeine (a non-selective adenosine receptor antagonist) prevents memory deficits in aging and Alzheimer's disease, an effect mimicked by adenosine A2 A receptor, but not A1 receptor, antagonists. Hence, we investigated the effects of adenosine receptor agonists and antagonists on memory performance and scopolamine-induced memory impairment in mice. EXPERIMENTAL APPROACH: We determined whether A2 A receptors are necessary for the emergence of memory impairments induced by scopolamine and whether A2 A receptor activation triggers memory deficits in naive mice, using three tests to assess short-term memory, namely the object recognition task, inhibitory avoidance and modified Y-maze. KEY RESULTS: Scopolamine (1.0 mg kg(-1) , i.p.) impaired short-term memory performance in all three tests and this scopolamine-induced amnesia was prevented by the A2 A receptor antagonist (SCH 58261, 0.1-1.0 mg kg(-1) , i.p.) and by the A1 receptor antagonist (DPCPX, 0.2-5.0 mg kg(-1) , i.p.), except in the modified Y-maze where only SCH58261 was effective. Both antagonists were devoid of effects on memory or locomotion in naive rats. Notably, the activation of A2 A receptors with CGS 21680 (0.1-0.5 mg kg(-1) , i.p.) before the training session was sufficient to trigger memory impairment in the three tests in naive mice, and this effect was prevented by SCH 58261 (1.0 mg kg(-1) , i.p.). Furthermore, i.c.v. administration of CGS 21680 (50 nmol) also impaired recognition memory in the object recognition task. CONCLUSIONS AND IMPLICATIONS: These results show that A2 A receptors are necessary and sufficient to trigger memory impairment and further suggest that A1 receptors might also be selectively engaged to control the cholinergic-driven memory impairment.
25939452	66	83	memory impairment	Disease	MESH:D008569
25939452	93	97	mice	Species	10090
25939452	123	131	Caffeine	Chemical	MESH:D002110
25939452	189	204	memory deficits	Disease	MESH:D008569
25939452	218	237	Alzheimer's disease	Disease	MESH:D000544
25939452	275	284	 receptor	Gene	11540
25939452	271	275	A2 A	DNAMutation	tmVar:c|SUB|A|2|A;HGVS:c.2A>A;VariantGroup:0;OriginalGene:11540;CorrespondingGene:135;CorrespondingSpecies:10090
25939452	428	439	scopolamine	Chemical	MESH:D012601
25939452	448	465	memory impairment	Disease	MESH:D008569
25939452	469	473	mice	Species	10090
25939452	520	524	A2 A	DNAMutation	tmVar:c|SUB|A|2|A;HGVS:c.2A>A;VariantGroup:0;OriginalGene:11540;CorrespondingGene:135;CorrespondingSpecies:10090
25939452	570	588	memory impairments	Disease	MESH:D008569
25939452	600	611	scopolamine	Chemical	MESH:D012601
25939452	624	628	A2 A	DNAMutation	tmVar:c|SUB|A|2|A;HGVS:c.2A>A;VariantGroup:0;OriginalGene:11540;CorrespondingGene:135;CorrespondingSpecies:10090
25939452	658	673	memory deficits	Disease	MESH:D008569
25939452	683	687	mice	Species	10090
25939452	827	838	Scopolamine	Chemical	MESH:D012601
25939452	862	888	impaired short-term memory	Disease	MESH:D008569
25939452	929	940	scopolamine	Chemical	MESH:D012601
25939452	949	956	amnesia	Disease	MESH:D000647
25939452	978	982	A2 A	DNAMutation	tmVar:c|SUB|A|2|A;HGVS:c.2A>A;VariantGroup:0;OriginalGene:11540;CorrespondingGene:135;CorrespondingSpecies:10090
25939452	1004	1013	SCH 58261	Chemical	MESH:C098657
25939452	1076	1081	DPCPX	Chemical	MESH:C051360
25939452	1151	1159	SCH58261	Chemical	MESH:C098657
25939452	1248	1252	rats	Species	10116
25939452	1281	1285	A2 A	DNAMutation	tmVar:c|SUB|A|2|A;HGVS:c.2A>A;VariantGroup:0;OriginalGene:11540;CorrespondingGene:135;CorrespondingSpecies:10090
25939452	1301	1310	CGS 21680	Chemical	MESH:C061282
25939452	1392	1409	memory impairment	Disease	MESH:D008569
25939452	1438	1442	mice	Species	10090
25939452	1477	1486	SCH 58261	Chemical	MESH:C098657
25939452	1549	1558	CGS 21680	Chemical	MESH:C061282
25939452	1574	1594	impaired recognition	Disease	MESH:D020238
25939452	1688	1692	A2 A	DNAMutation	tmVar:c|SUB|A|2|A;HGVS:c.2A>A;VariantGroup:0;OriginalGene:11540;CorrespondingGene:135;CorrespondingSpecies:10090
25939452	1743	1760	memory impairment	Disease	MESH:D008569
25939452	1867	1884	memory impairment	Disease	MESH:D008569
25939452	Positive_Correlation	MESH:C061282	HGVS:c.2A>A;CorrespondingGene:135
25939452	Positive_Correlation	MESH:C061282	MESH:D020238
25939452	Association	HGVS:c.2A>A;CorrespondingGene:135	MESH:D008569
25939452	Negative_Correlation	MESH:C098657	HGVS:c.2A>A;CorrespondingGene:135
25939452	Negative_Correlation	MESH:C051360	MESH:D012601
25939452	Association	MESH:D012601	HGVS:c.2A>A;CorrespondingGene:135
25939452	Positive_Correlation	MESH:D012601	MESH:D008569
25939452	Association	HGVS:c.2A>A;CorrespondingGene:135	MESH:D000544
25939452	Negative_Correlation	MESH:C098657	MESH:D008569
25939452	Negative_Correlation	MESH:C051360	MESH:D008569
25939452	Positive_Correlation	MESH:D012601	MESH:D000647
25939452	Negative_Correlation	MESH:C098657	MESH:D000647
25939452	Association	HGVS:c.2A>A;CorrespondingGene:135	MESH:D000647
25939452	Negative_Correlation	MESH:C051360	MESH:D000647
25939452	Positive_Correlation	MESH:C061282	MESH:D008569
25939452	Negative_Correlation	MESH:C098657	MESH:D012601
25939452	Negative_Correlation	MESH:D002110	MESH:D000544
25939452	Negative_Correlation	MESH:C061282	MESH:C098657
25939452	Negative_Correlation	MESH:D002110	MESH:D008569
25939452	Association	MESH:D008569	135
25939452	Association	MESH:D000544	135
25939452	Association	MESH:D000647	135

